Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Immortals vs Trimi

Immortals
Graded #286

Lower grade

vs+24.60000000000001
Trimi
Graded #7

Higher grade

The verdict

Trimi takes it — 86.4/100 to 61.8/100.

Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTrimi +39
54
93
Dose & formulationTrimi +20
64
84
Clinical oversightImmortals +6
88
82
Labs & monitoringTrimi +29
54
83
FulfillmentTrimi +22
68
90
Contract termsTrimi +64
20
84
Immortals · left barTrimi · right bar

The numbers

MetricImmortalsTrimi
WeighScore61.8/10086.4/100
GradeCB
Scorecard rank#286#7
Semaglutide$167/mo (microdose tier, compounded)$129/mo
Tirzepatide$180/mo (microdose tier, compounded)$199/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Immortals

Graded #286 · C

Strengths

  • LegitScript certified (ID 50458743) with board-certified U.S. physician review within 72 hours
  • Physician consult + prescription bundled in price — 'You pay for treatment. That's it' with no added fees
  • Competitive pricing: semaglutide microdose from $167/month, tirzepatide from $180/month (promotional)
  • Unlimited provider messaging for 12 months included; video consults available
  • Founded by Bryan Johnson and Kate Tolo; clinical lead Dr. Carl Seger, M.D. (preventive/longevity medicine)

Where it loses points

  • Microdose framing uses sub-clinical doses — lower weight-loss efficacy than standard GLP-1 protocols
  • Quarterly commitment only — 3-month minimum, paid upfront ($501–$540/quarter); no monthly flexibility
  • State availability not publicly listed; 'eligible U.S. states' with no specific state list
  • Labs not included; baseline bloodwork protocol not disclosed on any public page
  • Compounding pharmacy not named; no 503A/503B accreditation details disclosed
Trimi

Graded #7 · B

Strengths

  • Low flat pricing on both semaglutide and tirzepatide
  • Both molecules on a single membership
  • Free shipping to all 50 states
  • Fast dispatch once the prescriber signs off

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • Injection only — no oral or sublingual route
  • Dispensing pharmacy not publicly named
  • Shorter public track record than the incumbents

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard